Ascentage Pharma Group International (AAPG) Non-Current Receivables (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Ascentage Pharma Group International (AAPG) has disclosed Non-Current Receivables for 2 consecutive years, with $3.6 million as the latest value for Q4 2024.

• For Q4 2024, Non-Current Receivables rose 270.04% year-over-year to $3.6 million; the TTM value through Dec 2024 reached $3.6 million, up 270.04%, while the annual FY2024 figure was $3.6 million, 257.56% up from the prior year.
• Non-Current Receivables hit $3.6 million in Q4 2024 for Ascentage Pharma Group International, up from $979433.9 in the prior quarter.
• Across five years, Non-Current Receivables topped out at $3.6 million in Q4 2024 and bottomed at $979433.9 in Q4 2023.

Peer Comparison